Haider Dominik G, Masghati Salome, Goliasch Georg, Fuhrmann Valentin, Soleiman Afschin, Wolzt Michael, Baierl Andreas, Druml Wilfred, Hörl Walter H
Division of Nephrology and Dialysis, Department of Internal Medicine III, General Hospital/Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.
J Nephrol. 2014 Dec;27(6):643-51. doi: 10.1007/s40620-014-0074-z. Epub 2014 Mar 8.
Glomerular filtration rate (GFR) in patients with chronic kidney disease (CKD) identifies patients at risk for death or end-stage renal disease (ESRD). CKD staging by GFR should incorporate proteinuria to augment risk stratification. We therefore tested the predictive power of the combination of GFR with proteinuria in patients with different histologically-diagnosed types of glomerulonephritis (GN).
In a retrospective analysis, 2,687 patients with different forms of GN from 123 Austrian centres were investigated. Full data sets were available from 1,892 subjects. Classes of CKD on the basis of estimated GFR (eGFR) and of proteinuria grouped as <1, 1-3.5, and >3.5 g/24 h were tested for their association with all-cause mortality and ESRD.
During a median follow-up of 130 months [interquartile range (IQR) 90; 178] 478 patients (25.3 %) died. Median eGFR was 49 ml/min/1.73 m(2) (IQR 24; 81) and proteinuria 3.8 g/24 h (IQR 1.7; 8.0). Adjusted multivariate Cox regression indicated that renal survival but not overall survival is related to proteinuria >3.5 g/24 h [as opposed to <1 g/24 h; hazard ratio (HR) 1.91] and shows progression to ESRD. However, subgroup analyses revealed that this risk with proteinuria >3.5 g/24 h exists only in patients with immunoglobulin (Ig)A GN (HR 4.93), miscellaneous GN (HR 1.74), and CKD stage 5 (HR 2.50). Additionally, proteinuria is a risk factor for renal survival in males more than in females with GN and proteinuria >3.5 g/24 h (HR 1.91).
Proteinuria is a strong risk factor for renal survival particularly in patients with proteinuria >3.5 g/24 but not for all types of GN, nor for all CKD stages. Proteinuria is not a risk factor for overall survival in patients with GN.
慢性肾脏病(CKD)患者的肾小球滤过率(GFR)可识别死亡或终末期肾病(ESRD)风险患者。基于GFR的CKD分期应纳入蛋白尿以增强风险分层。因此,我们测试了GFR与蛋白尿相结合对不同组织学诊断类型的肾小球肾炎(GN)患者的预测能力。
在一项回顾性分析中,对来自奥地利123个中心的2687例不同形式GN患者进行了调查。1892名受试者可获得完整数据集。基于估计肾小球滤过率(eGFR)和蛋白尿分为<1、1 - 3.5和>3.5 g/24小时的CKD类别,测试其与全因死亡率和ESRD的关联。
在中位随访130个月[四分位间距(IQR)90;178]期间,478例患者(25.3%)死亡。中位eGFR为49 ml/min/1.73 m²(IQR 24;81),蛋白尿为3.8 g/24小时(IQR 1.7;8.0)。校正后的多因素Cox回归表明,肾脏生存率而非总生存率与蛋白尿>3.5 g/24小时相关[与<1 g/24小时相比;风险比(HR)1.91],并显示进展为ESRD。然而,亚组分析显示,蛋白尿>3.5 g/24小时的这种风险仅存在于免疫球蛋白(Ig)A肾病(HR 4.93)、其他类型GN(HR 1.74)和CKD 5期(HR 2.50)患者中。此外,蛋白尿>3.5 g/24小时的男性GN患者的肾脏生存风险高于女性(HR 1.91)。
蛋白尿是肾脏生存的强风险因素,尤其是蛋白尿>3.5 g/24小时的患者,但并非对所有类型的GN或所有CKD阶段均如此。蛋白尿不是GN患者总生存的风险因素。